Word Of Mouth At Emisphere

The stock of Emisphere Technol Jan. 14 above 23. No, this little drug outfit hasn't come up with a cure for cancer. In fact, it has yet to produce revenues. What gives?

To continue reading this article you must be a Bloomberg Professional Service Subscriber.